산업 일반
Nike shares surge over 10% in after-hours trading despite weak earnings… “We’ll reduce our exposure to Chinese-made products”

This was because it presented a strategy to improve future performance. Nike announced that revenue for the March–May fiscal fourth quarter was $11.1 billion. This figure exceeded market expectations but was the lowest since the third quarter of fiscal year 2022. Net profit plummeted 86% year-on-year to $211 million, its lowest since the fourth quarter of fiscal year 2020.
Nevertheless, CEO Elliott Hill expressed optimism during the earnings call, saying, “We expect business performance to improve from here. It’s time to turn the page.” Hill returned as Nike CEO last October and has since strengthened ties with retailers, prioritized running shoes and athletic wear, and implemented strategic price hikes. The launch of new models such as Pegasus and Vomero helped drive a recovery in the running shoe category.
If the Trump administration, which is likely to return to power, enforces a comprehensive import tariff policy, Nike could face additional annual costs of up to $1 billion. Currently, about 16% of footwear imported into the United States is made in China, making it especially vulnerable to tariff hikes.
Nike plans to reduce the proportion of Chinese-made shoes from the current approximately 16% to single digits by the end of fiscal year 2026. It is also planning to raise product prices.
▶원문 기사: 나이키, 저조한 실적 불구 시간외 급등…“중국산 비중 줄일 것” (이코노미스트, 2025. 6.27)

ⓒ이코노미스트(https://economist.co.kr) '내일을 위한 경제뉴스 이코노미스트' 무단 전재 및 재배포 금지
당신이 좋아할 만한 기사
브랜드 미디어
브랜드 미디어
핀테라퓨틱스-임프리메드 MOU 체결, 혈액암 분야 L/O 박차
바이오 성공 투자, 1%를 위한 길라잡이이데일리
이데일리
이데일리
'소시 태연 아냐' 김태연 측 "강한 유감" 왜?
대한민국 스포츠·연예의 살아있는 역사 일간스포츠일간스포츠
일간스포츠
일간스포츠
리스크로 떠오른 '파월 해임안'…트럼프 vs 월가 '힘겨루기'
세상을 올바르게,세상을 따뜻하게이데일리
이데일리
이데일리
"실체는 그게 아닌데"…모회사 뒷배 반영, 투자판단 흐린다
성공 투자의 동반자마켓인
마켓인
마켓인
‘구글 픽’ 멧세라, 디앤디파마텍 통해 경구용 비만약 강자로 도약할까
바이오 성공 투자, 1%를 위한 길라잡이팜이데일리
팜이데일리
팜이데일리